| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:HDL-16 CAS:2373280-36-3 Purity:97.58% Package:1removed
|
|
| | HDL-16 Chemical Properties |
| Boiling point | 438.247±30.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.547±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 2.206±0.50(predicted) | | form | Solid | | color | White to off-white |
| | HDL-16 Usage And Synthesis |
| Uses | HDL-16 is a potent P2Y14R antagonist with an IC50of0.3095nM. HDL-16 ameliorates DSS (HY-116282C)-induced colitis through suppressing necroptosis of intestinal epithelium cells (IECs) and protecting mucosal barrier function[1]. | | in vivo | HDL-16 (10μM or 20μM; 100μL; Rectally administered; daily; 6 days) with high-dose significantly suppresses colitis symptoms and leads to maintained gut barrier integrity in the mice[1].
| Animal Model: | Male, 7-8-week-old, P2Y14Rfl/fl Vil-cre (P2Y14RIEC), P2Y14Rfl/fl Lyz2-cre and WT mice with C57BL/6J background[1] | | Dosage: | 10μM or 20μM; 100μL | | Administration: | Rectally administered; daily; 6 days | | Result: | With high-dose showed dramatically less body weight loss and lower Disease Activity Index (DAI) than Dextran sodium sulfate (DSS; 36-50kDa; 3% w/v; drinking water for 7 days)-exposed mice.
With high-dose improved DSS-induced inflammatory infiltration and tissue damage.
With high-dose resulted in a prominently suppression in necroptosis of the IECs in DSS-treated mice.
|
| | IC 50 | P2Y14 Receptor: 0.3095 nM (IC50) | | References | [1] Chunxiao Liu, et al. Targeting P2Y14R protects against necroptosis of intestinal epithelial cells through PKA/CREB/RIPK1 axis in ulcerative colitis. Nat Commun. 2024 Mar 7;15(1):2083. DOI:10.1038/s41467-024-46365-x |
| | HDL-16 Preparation Products And Raw materials |
|